Statistics from Altmetric.com
Ever since inhaled corticosteroids (ICS) were first introduced as an effective prophylactic agent, there has been a debate over whether asthma exacerbations can be treated by increasing the dose. In theory, as we know systemic steroids are highly effective, they should work. A popular strategy is doubling the dose at the first sign of an exacerbation (sometimes termed the ‘yellow zone’), but trials have not shown this to be effective. Could increasing the dose by a factor of four or five work better?
The NEJM recently published two trials side-by-side addressing this question, which came to opposing conclusions. The first, from multiple …
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.